• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    88.21 Down 8.79(9.06%) Apr 29, 4:00PM EDT
    |After Hours : 88.37 Up 0.16 (0.18%) Apr 29, 7:57PM EDT
    Prev Close:97.00
    Open:91.19
    Bid:88.25 x 100
    Ask:88.38 x 200
    1y Target Est:114.29
    Beta:1.25203
    Earnings Date:Jul 26 - Aug 1 (Est.)
    Day's Range:87.80 - 92.53
    52wk Range:81.89 - 123.37
    Volume:33,629,186
    Avg Vol (3m):12,641,200
    Market Cap:119.49B
    P/E (ttm):7.41
    EPS (ttm):11.91
    Div & Yield:1.72 (1.70%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 9.06%119.49B
    GSKDown 1.04%103.84B
    PFEDown 0.61%202.54B

    Key Statistics

    Forward P/E (1 yr):7.09
    P/S (ttm):4.06
    Ex-Dividend Date:14-Mar-16

    Analysts

    Annual EPS Est (Dec-16) :12.33
    Quarterly EPS Est (Jun-16) :3.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):6.73

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback